New Goals and Strategies of Chinese Medicine in Prevention and Treatment of Chronic Kidney Disease.
10.1007/s11655-019-3065-z
- Author:
Chuan GUO
1
;
Shen LI
1
;
Xiang-Rong RAO
2
Author Information
1. Department of Nephrology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.
2. Department of Nephrology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China. raoyisheng@163.com.
- Publication Type:Journal Article
- Keywords:
Chinese medicine;
blood stasis;
chronic kidney disease;
strategies;
turbid toxin
- MeSH:
Hemostasis;
Humans;
Medicine, Chinese Traditional;
Renal Insufficiency, Chronic;
blood;
drug therapy;
etiology;
prevention & control
- From:
Chinese journal of integrative medicine
2019;25(3):163-167
- CountryChina
- Language:English
-
Abstract:
Chronic kidney disease (CKD) is a clinical syndrome with a series of clinical manifestations and metabolic disorders caused by many diseases, which are characterized by progressive deterioration or irreversible damage of renal structures and functions. With the progress of epidemiological research, CKD has brought about huge economic and psychological burdens. There is a considerable risk of cardiovascular events or death than progression to end-stage renal disease for patients. Particular attentions should be paid to the new goals of reducing cardiovascular events and all-cause mortality. It is important to analyze the etiology and pathogenesis according to patients' ages, regions, primary disease as well as different stages of disease, and choose the appropriate therapeutic strategies accordingly. In clinical practice, due to the uncertainty of therapeutic effects of modern medicine based on the risk factors, it is necessary to use Chinese medicine (CM) to delay the disease progression and reduce comorbidities. Turbid toxin and blood stasis are two critical pathological factors worthy of concerns in the theory of CM. In addition, appropriate use of CM may help improve the quality of life of patients with CKD.
